AAAAAA
Results:
1-7
|
Results: 7
Authors:
Wiedswang, G
Naess, AB
Naume, B
Karesen, R
Citation: G. Wiedswang et al., Micrometastasis to axillary lymph nodes and bone marrow in breast cancer patients, BREAST, 10(3), 2001, pp. 237-242
Authors:
Ekeberg, O
Skjauff, H
Karesen, R
Citation: O. Ekeberg et al., Screening for breast cancer is associated with a low degree of psychological distress, BREAST, 10(1), 2001, pp. 20-24
Authors:
Wang, H
Karesen, R
Hervik, A
Thoresen, SO
Citation: H. Wang et al., Mammography screening in Norway: results from the first screening round infour counties and cost-effectiveness of a modeled nationwide screening, CANC CAUSE, 12(1), 2001, pp. 39-45
Authors:
Kristensen, VN
Harada, N
Yoshimura, N
Haraldsen, E
Lonning, P
Erikstein, B
Karesen, R
Kristensen, T
Borresen-Dale, AL
Citation: Vn. Kristensen et al., Genetic variants of CYP19 (aromatase) and breast cancer risk, ONCOGENE, 19(10), 2000, pp. 1329-1333
Authors:
Wang, HG
Jebsen, PW
Karesen, R
Thoresen, SO
Citation: Hg. Wang et al., Ductal carcinoma in situ of the breast - A review of diagnosis, treatment and outcome in a hospital-based Norwegian series, ACTA ONCOL, 39(2), 2000, pp. 131-134
Authors:
Laake, K
Vu, P
Andersen, TI
Erikstein, B
Karesen, R
Lonning, PE
Skovlund, E
Borresen-Dale, AL
Citation: K. Laake et al., Screening breast cancer patients for Norwegian ATM mutations, BR J CANC, 83(12), 2000, pp. 1650-1653
Authors:
Kristensen, VN
Haraldsen, EK
Anderson, KB
Lonning, PE
Erikstein, B
Karesen, R
Gabrielsen, OS
Borresen-Dale, AL
Citation: Vn. Kristensen et al., CYP17 and breast cancer risk: The polymorphism in the 5 ' flanking area ofthe gene does not influence binding to Sp-1, CANCER RES, 59(12), 1999, pp. 2825-2828
Risultati:
1-7
|